As AI transforms how therapies are discovered, developed, and funded, the convergence of technology and capital is reshaping the future of biotech. Held alongside the Jefferies London Healthcare Conference, the GenScript Biotech Global Forum – London Executive Reception will take place on 17 November 2026 in London.

Under the theme AI, Biotech & Capital, this exclusive evening will bring together biotech and pharma leaders, investors, and partners for candid conversations and networking opportunities. Rather than a full-day program, this year's gathering is a relationship-first evening, anchored around a fireside chat that will explore how AI is influencing investment decisions, therapeutic development, and where the smart money is heading next.

The conversation will feature:

•  Alan Belicha, PhD - Sr. Director, Ecosystem Growth and Contributor Partnerships, Eli Lilly and Company
•  Simon Kohl, PhD - Founder & CEO, Latent Labs
•  Edward Kliphuis - Partner, Digital Medicine Strategy, Sofinnova Partners
•  Richard Pearce - Chief Business Officer, Basecamp Research
•  Aylin Kosova Bilgin - Chief Marketing & Corporate Communications Officer, GenScript
•  Zhenyan Yan, PhD - VP of Corporate Development & Strategy, GenScript

We invite you to join us in person for this exclusive executive reception in London.